Profile data is unavailable for this security.
About the company
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for single cell and spatial biology systems. Its single cell portfolio, powered by Chromium platform, includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Visium Spatial Gene Expression, and others.
- Revenue in USD (TTM)642.82m
- Net income in USD-43.54m
- Incorporated2012
- Employees1.18k
- Location10X Genomics Inc6230 Stoneridge Mall RoadPLEASANTON 94588United StatesUSA
- Phone+1 (925) 401-7300
- Fax+1 (302) 655-5049
- Websitehttps://www.10xgenomics.com/
More ▼
Mergers & acquisitions
| Acquired company | TXG:NSQ since announced | Transaction value |
|---|---|---|
| Scale Biosciences Inc | 78.67% | 30.00m |
Data delayed at least 15 minutes, as of Mar 03 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tandem Diabetes Care Inc | 1.01bn | -204.71m | 1.62bn | 2.50k | -- | 10.45 | -- | 1.60 | -3.07 | -3.07 | 15.08 | 2.27 | 1.10 | 3.37 | 7.25 | 405,894.40 | -22.15 | -12.88 | -30.13 | -16.00 | 53.81 | 52.12 | -20.17 | -14.32 | 2.02 | -6.00 | 0.6699 | -- | 7.93 | 15.26 | -113.18 | -- | -9.19 | -- |
| Artivion Inc | 441.33m | 9.76m | 1.85bn | 1.80k | 194.39 | 4.12 | 57.38 | 4.19 | 0.1987 | 0.1987 | 9.44 | 9.37 | 0.5273 | 1.82 | 5.22 | 245,183.30 | 1.17 | -1.72 | 1.30 | -1.86 | 64.40 | 64.69 | 2.21 | -3.80 | 2.62 | 1.44 | 0.3278 | -- | 13.59 | 11.75 | 173.17 | -- | 39.74 | -- |
| Omnicell Inc | 1.18bn | 2.05m | 1.85bn | 3.58k | 944.01 | 1.49 | 22.64 | 1.56 | 0.0432 | 0.0432 | 25.70 | 27.36 | 0.5786 | 7.19 | 5.01 | 330,962.30 | 0.1002 | 0.7331 | 0.1357 | 0.9767 | 42.49 | 44.88 | 0.1732 | 1.32 | 1.22 | -- | 0.1198 | 0.00 | 6.53 | 5.84 | -83.62 | -42.34 | 1.93 | -- |
| Inspire Medical Systems Inc | 911.98m | 145.42m | 1.88bn | 1.33k | 13.24 | 2.41 | 11.80 | 2.06 | 4.97 | 4.97 | 30.75 | 27.33 | 1.06 | 1.18 | 8.57 | 684,156.80 | 16.95 | 3.09 | 19.00 | 3.48 | 85.39 | 84.83 | 15.95 | 3.05 | 4.56 | -- | 0.00 | 0.00 | 13.60 | 51.21 | 171.77 | -- | 73.41 | -- |
| Alphatec Holdings Inc | 764.16m | -143.36m | 1.97bn | 913.00 | -- | 157.44 | -- | 2.58 | -0.9598 | -0.9598 | 5.09 | 0.2398 | 0.9754 | 1.35 | 7.86 | 836,971.50 | -18.30 | -24.58 | -24.00 | -31.32 | 69.60 | 67.58 | -18.76 | -32.07 | 1.28 | -1.28 | 0.9402 | -- | 24.95 | 39.46 | 11.57 | -- | 16.50 | -- |
| Heartflow Inc | -100.00bn | -100.00bn | 2.03bn | 699.00 | -- | 7.83 | -- | -- | -- | -- | -- | 3.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | 44.32 | -- | 22.04 | -- | -- | -- |
| Establishment Labs Holdings Inc | 211.08m | -51.06m | 2.09bn | 1.00k | -- | 88.50 | -- | 9.88 | -1.74 | -1.74 | 7.17 | 0.8035 | 0.5997 | 0.788 | 2.96 | 210,235.10 | -14.51 | -27.03 | -18.45 | -33.98 | 69.32 | 66.79 | -24.19 | -39.79 | 2.00 | -2.12 | 0.9131 | -- | 27.14 | 20.04 | 39.64 | -- | 11.46 | -- |
| Neogen Corp | 880.32m | -602.74m | 2.37bn | 2.97k | -- | 1.13 | -- | 2.69 | -2.78 | -2.78 | 4.05 | 9.67 | 0.2375 | 2.63 | 5.95 | 296,005.00 | -16.26 | -7.73 | -16.94 | -8.06 | 45.98 | 48.10 | -68.47 | -27.91 | 2.80 | -0.2109 | 0.2737 | -- | -3.20 | 16.43 | -11,491.59 | -- | 34.18 | -- |
| LeMaitre Vascular Inc | 249.60m | 57.73m | 2.46bn | 646.00 | 43.61 | 6.24 | 36.05 | 9.84 | 2.47 | 2.47 | 10.72 | 17.28 | 0.4276 | 1.05 | 7.84 | 386,380.80 | 9.89 | 9.27 | 10.49 | 9.98 | 71.53 | 67.70 | 23.13 | 18.33 | 10.95 | -- | 0.300 | 36.37 | 13.53 | 14.05 | 31.10 | 22.16 | 17.86 | 18.10 |
| DENTSPLY SIRONA Inc | 3.68bn | -598.00m | 2.66bn | 14.00k | -- | 1.98 | -- | 0.7219 | -3.00 | -3.00 | 18.44 | 6.71 | 0.6582 | 3.05 | 5.92 | 262,857.20 | -10.70 | -5.83 | -14.50 | -7.12 | 50.00 | 52.93 | -16.25 | -11.12 | 1.03 | 4.77 | 0.6347 | -- | -2.98 | 1.96 | 34.29 | -- | 8.53 | 9.86 |
| 10X Genomics Inc | 642.82m | -43.54m | 2.89bn | 1.18k | -- | 3.63 | -- | 4.50 | -0.3496 | -0.3496 | 5.15 | 6.24 | 0.6559 | 2.85 | 9.53 | 545,690.10 | -4.44 | -14.35 | -5.16 | -16.43 | 69.13 | 72.27 | -6.77 | -24.50 | 4.09 | -- | 0.00 | -- | 5.25 | 16.55 | 76.16 | -- | -31.16 | -- |
| Integer Holdings Corp | 1.85bn | 102.83m | 2.98bn | 11.00k | 30.20 | 1.71 | 12.78 | 1.61 | 2.87 | 2.87 | 52.83 | 50.85 | 0.5714 | 5.37 | 4.59 | -- | 3.17 | 3.26 | 3.41 | 3.51 | 27.39 | 26.88 | 5.55 | 6.07 | 2.23 | 6.04 | 0.41 | -- | 7.98 | 11.54 | -15.05 | 5.89 | 12.09 | -- |
| Haemonetics Corp | 1.32bn | 175.44m | 3.05bn | 3.02k | 18.03 | 3.37 | 10.59 | 2.31 | 3.64 | 3.64 | 27.40 | 19.46 | 0.525 | 1.58 | 6.47 | 436,081.70 | 6.99 | 5.41 | 8.30 | 6.55 | 59.32 | 53.20 | 13.31 | 9.18 | 1.15 | 12.69 | 0.5733 | 0.00 | 3.95 | 6.60 | 42.64 | 16.99 | 4.37 | -- |
| ICU Medical Inc | 2.23bn | 732.00k | 3.52bn | 13.00k | 5,780.39 | 1.66 | 17.22 | 1.58 | 0.0247 | 0.0247 | 90.50 | 86.03 | 0.5406 | 2.35 | 12.28 | 171,635.50 | 0.0465 | -0.6518 | 0.0534 | -0.7376 | 36.84 | 34.16 | 0.0861 | -1.11 | 1.15 | 1.70 | 0.378 | -- | -6.33 | 11.91 | 100.62 | -61.53 | -0.6816 | -- |
| LivaNova PLC | 1.39bn | -242.47m | 3.74bn | 3.30k | -- | 3.12 | -- | 2.70 | -4.47 | -4.47 | 25.37 | 21.96 | 0.543 | 2.84 | 6.79 | 420,622.10 | -9.48 | -3.21 | -12.39 | -3.97 | 68.04 | 68.27 | -17.46 | -6.55 | 1.16 | 3.67 | 0.2389 | -- | 10.74 | 8.24 | -483.45 | -- | 18.27 | -- |
| iRhythm Holdings, Inc | 747.14m | -44.55m | 4.07bn | 2.40k | -- | 26.61 | -- | 5.44 | -1.41 | -1.41 | 23.35 | 4.73 | 0.7657 | 12.33 | 9.60 | 311,307.50 | -4.57 | -16.40 | -5.28 | -19.65 | 70.57 | 68.67 | -5.96 | -19.44 | 4.48 | -- | 0.8096 | -- | 26.24 | 23.02 | 60.67 | -- | 27.88 | -- |
Data as of Mar 03 2026. Currency figures normalised to 10X Genomics Inc's reporting currency: US Dollar USD
57.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| ARK Investment Management LLCas of 31 Dec 2025 | 12.67m | 10.88% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 12.10m | 10.39% |
| Fidelity Management & Research Co. LLCas of 31 Dec 2025 | 9.75m | 8.37% |
| BlackRock Fund Advisorsas of 31 Dec 2025 | 8.29m | 7.12% |
| Amova Asset Management Co., Ltd.as of 31 Dec 2025 | 5.49m | 4.72% |
| Amova Asset Management Americas, Inc.as of 31 Dec 2025 | 5.49m | 4.71% |
| Quantinno Capital Management LPas of 31 Dec 2025 | 4.67m | 4.01% |
| Geode Capital Management LLCas of 31 Dec 2025 | 2.79m | 2.40% |
| Jacobs Levy Equity Management, Inc.as of 31 Dec 2025 | 2.64m | 2.27% |
| AQR Capital Management LLCas of 31 Dec 2025 | 2.58m | 2.21% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
